BioCentury
ARTICLE | Financial News

KaloBios sets IPO range

January 16, 2013 2:28 AM UTC

Antibody company KaloBios Pharmaceuticals Inc. (South San Francisco, Calif.) amended its IPO and now plans to sell 3.9 million shares at $12-$14. A $13 price would raise $50.1 million and value the company at $238.5 million. The company proposed to raise up to $60 million in an IPO in October 2012 after becoming a publicly reporting company via the Form 10 pathway in August. Leerink; William Blair; and Needham are underwriters. ...